This content is machine translated MASLD/MASH Drug therapy options on the rise: spectacular evidence Over the last few decades, the incidence of steatotic liver disease has risen in parallel with the increase in obesity, diabetes and other metabolic diseases. It is recommended to screen...…
View Post 5 min This content is machine translated Cardiometabolic research The liver-heart axis in the pathogenesis of cardiometabolic diseases The close functional connection between the liver and the heart plays a central role in the development and progression of cardiometabolic diseases. While cardiovascular and hepatic pathologies have long been...…
View Post 12 min This content is machine translated Liver steatosis with metabolic dysfunction New nomenclature for non-alcoholic fatty liver disease The term “non-alcoholic steatohepatitis” (NASH) was originally used to describe liver damage characterized by lobular inflammation, steatosis and ballooning of hepatocytes. In addition, a large proportion of patients were described...… CME-Test
View Post 12 min This content is machine translated Liver steatosis with metabolic dysfunction New nomenclature for non-alcoholic fatty liver disease The term “non-alcoholic steatohepatitis” (NASH) was originally used to describe liver damage characterized by lobular inflammation, steatosis and ballooning of hepatocytes. In addition, a large proportion of patients were described...… CME-Test
View Post 5 min This content is machine translated Metabolic Dysfunction-Associated Steatotic Liver Disease Cardiology and hepatology in one boat Metabolic dysfunction has far-reaching negative effects on the body, which can manifest as cardiovascular and liver disease. Traditionally, these conditions have been treated in an organ-centered manner, resulting in isolated…
